Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Sulphonamides Market Growth 2022-2028

  • LP 4743888
  • 105 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Sulphonamides will have significant change from previous year. According to our (LP Information) latest study, the global Sulphonamides market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sulphonamides market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Sulphonamides market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sulphonamides market, reaching US$ million by the year 2028. As for the Europe Sulphonamides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Sulphonamides players cover Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Sulphonamides market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Orally Absorbable Sulfonamide

Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Skin Infections

Gastro Intestinal Tract (GIT) Infection

Meningitis

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Abbott Laboratories

Boehringer Ingelheim Pharmaceuticals

Bayer AG

GlaxoSmithKline

King Pharmaceuticals

Mylan Pharmaceuticals

Novartis International AG

Pfizer

Par Pharmaceutical

Roche Holding AG

Sanofi Aventis

Stiefel Laboratories

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sulphonamides Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sulphonamides by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sulphonamides by Country/Region, 2017, 2022 & 2028

2.2 Sulphonamides Segment by Type

2.2.1 Orally Absorbable Sulfonamide

2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

2.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

2.3 Sulphonamides Sales by Type

2.3.1 Global Sulphonamides Sales Market Share by Type (2017-2022)

2.3.2 Global Sulphonamides Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sulphonamides Sale Price by Type (2017-2022)

2.4 Sulphonamides Segment by Application

2.4.1 Skin Infections

2.4.2 Gastro Intestinal Tract (GIT) Infection

2.4.3 Meningitis

2.5 Sulphonamides Sales by Application

2.5.1 Global Sulphonamides Sale Market Share by Application (2017-2022)

2.5.2 Global Sulphonamides Revenue and Market Share by Application (2017-2022)

2.5.3 Global Sulphonamides Sale Price by Application (2017-2022)

3 Global Sulphonamides by Company

3.1 Global Sulphonamides Breakdown Data by Company

3.1.1 Global Sulphonamides Annual Sales by Company (2020-2022)

3.1.2 Global Sulphonamides Sales Market Share by Company (2020-2022)

3.2 Global Sulphonamides Annual Revenue by Company (2020-2022)

3.2.1 Global Sulphonamides Revenue by Company (2020-2022)

3.2.2 Global Sulphonamides Revenue Market Share by Company (2020-2022)

3.3 Global Sulphonamides Sale Price by Company

3.4 Key Manufacturers Sulphonamides Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sulphonamides Product Location Distribution

3.4.2 Players Sulphonamides Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sulphonamides by Geographic Region

4.1 World Historic Sulphonamides Market Size by Geographic Region (2017-2022)

4.1.1 Global Sulphonamides Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sulphonamides Annual Revenue by Geographic Region

4.2 World Historic Sulphonamides Market Size by Country/Region (2017-2022)

4.2.1 Global Sulphonamides Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sulphonamides Annual Revenue by Country/Region

4.3 Americas Sulphonamides Sales Growth

4.4 APAC Sulphonamides Sales Growth

4.5 Europe Sulphonamides Sales Growth

4.6 Middle East & Africa Sulphonamides Sales Growth

5 Americas

5.1 Americas Sulphonamides Sales by Country

5.1.1 Americas Sulphonamides Sales by Country (2017-2022)

5.1.2 Americas Sulphonamides Revenue by Country (2017-2022)

5.2 Americas Sulphonamides Sales by Type

5.3 Americas Sulphonamides Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sulphonamides Sales by Region

6.1.1 APAC Sulphonamides Sales by Region (2017-2022)

6.1.2 APAC Sulphonamides Revenue by Region (2017-2022)

6.2 APAC Sulphonamides Sales by Type

6.3 APAC Sulphonamides Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sulphonamides by Country

7.1.1 Europe Sulphonamides Sales by Country (2017-2022)

7.1.2 Europe Sulphonamides Revenue by Country (2017-2022)

7.2 Europe Sulphonamides Sales by Type

7.3 Europe Sulphonamides Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sulphonamides by Country

8.1.1 Middle East & Africa Sulphonamides Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sulphonamides Revenue by Country (2017-2022)

8.2 Middle East & Africa Sulphonamides Sales by Type

8.3 Middle East & Africa Sulphonamides Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sulphonamides

10.3 Manufacturing Process Analysis of Sulphonamides

10.4 Industry Chain Structure of Sulphonamides

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sulphonamides Distributors

11.3 Sulphonamides Customer

12 World Forecast Review for Sulphonamides by Geographic Region

12.1 Global Sulphonamides Market Size Forecast by Region

12.1.1 Global Sulphonamides Forecast by Region (2023-2028)

12.1.2 Global Sulphonamides Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sulphonamides Forecast by Type

12.7 Global Sulphonamides Forecast by Application

13 Key Players Analysis

13.1 Abbott Laboratories

13.1.1 Abbott Laboratories Company Information

13.1.2 Abbott Laboratories Sulphonamides Product Offered

13.1.3 Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Laboratories Main Business Overview

13.1.5 Abbott Laboratories Latest Developments

13.2 Boehringer Ingelheim Pharmaceuticals

13.2.1 Boehringer Ingelheim Pharmaceuticals Company Information

13.2.2 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Offered

13.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview

13.2.5 Boehringer Ingelheim Pharmaceuticals Latest Developments

13.3 Bayer AG

13.3.1 Bayer AG Company Information

13.3.2 Bayer AG Sulphonamides Product Offered

13.3.3 Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer AG Main Business Overview

13.3.5 Bayer AG Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Sulphonamides Product Offered

13.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 King Pharmaceuticals

13.5.1 King Pharmaceuticals Company Information

13.5.2 King Pharmaceuticals Sulphonamides Product Offered

13.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 King Pharmaceuticals Main Business Overview

13.5.5 King Pharmaceuticals Latest Developments

13.6 Mylan Pharmaceuticals

13.6.1 Mylan Pharmaceuticals Company Information

13.6.2 Mylan Pharmaceuticals Sulphonamides Product Offered

13.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Mylan Pharmaceuticals Main Business Overview

13.6.5 Mylan Pharmaceuticals Latest Developments

13.7 Novartis International AG

13.7.1 Novartis International AG Company Information

13.7.2 Novartis International AG Sulphonamides Product Offered

13.7.3 Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis International AG Main Business Overview

13.7.5 Novartis International AG Latest Developments

13.8 Pfizer

13.8.1 Pfizer Company Information

13.8.2 Pfizer Sulphonamides Product Offered

13.8.3 Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Main Business Overview

13.8.5 Pfizer Latest Developments

13.9 Par Pharmaceutical

13.9.1 Par Pharmaceutical Company Information

13.9.2 Par Pharmaceutical Sulphonamides Product Offered

13.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Par Pharmaceutical Main Business Overview

13.9.5 Par Pharmaceutical Latest Developments

13.10 Roche Holding AG

13.10.1 Roche Holding AG Company Information

13.10.2 Roche Holding AG Sulphonamides Product Offered

13.10.3 Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Roche Holding AG Main Business Overview

13.10.5 Roche Holding AG Latest Developments

13.11 Sanofi Aventis

13.11.1 Sanofi Aventis Company Information

13.11.2 Sanofi Aventis Sulphonamides Product Offered

13.11.3 Sanofi Aventis Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sanofi Aventis Main Business Overview

13.11.5 Sanofi Aventis Latest Developments

13.12 Stiefel Laboratories

13.12.1 Stiefel Laboratories Company Information

13.12.2 Stiefel Laboratories Sulphonamides Product Offered

13.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Stiefel Laboratories Main Business Overview

13.12.5 Stiefel Laboratories Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Sulphonamides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sulphonamides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Orally Absorbable Sulfonamide

Table 4. Major Players of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

Table 5. Major Players of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

Table 6. Global Sulphonamides Sales by Type (2017-2022) & (K MT)

Table 7. Global Sulphonamides Sales Market Share by Type (2017-2022)

Table 8. Global Sulphonamides Revenue by Type (2017-2022) & ($ million)

Table 9. Global Sulphonamides Revenue Market Share by Type (2017-2022)

Table 10. Global Sulphonamides Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Sulphonamides Sales by Application (2017-2022) & (K MT)

Table 12. Global Sulphonamides Sales Market Share by Application (2017-2022)

Table 13. Global Sulphonamides Revenue by Application (2017-2022)

Table 14. Global Sulphonamides Revenue Market Share by Application (2017-2022)

Table 15. Global Sulphonamides Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Sulphonamides Sales by Company (2020-2022) & (K MT)

Table 17. Global Sulphonamides Sales Market Share by Company (2020-2022)

Table 18. Global Sulphonamides Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Sulphonamides Revenue Market Share by Company (2020-2022)

Table 20. Global Sulphonamides Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Sulphonamides Producing Area Distribution and Sales Area

Table 22. Players Sulphonamides Products Offered

Table 23. Sulphonamides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Sulphonamides Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Sulphonamides Sales Market Share Geographic Region (2017-2022)

Table 28. Global Sulphonamides Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Sulphonamides Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Sulphonamides Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Sulphonamides Sales Market Share by Country/Region (2017-2022)

Table 32. Global Sulphonamides Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Sulphonamides Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Sulphonamides Sales by Country (2017-2022) & (K MT)

Table 35. Americas Sulphonamides Sales Market Share by Country (2017-2022)

Table 36. Americas Sulphonamides Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Sulphonamides Revenue Market Share by Country (2017-2022)

Table 38. Americas Sulphonamides Sales by Type (2017-2022) & (K MT)

Table 39. Americas Sulphonamides Sales Market Share by Type (2017-2022)

Table 40. Americas Sulphonamides Sales by Application (2017-2022) & (K MT)

Table 41. Americas Sulphonamides Sales Market Share by Application (2017-2022)

Table 42. APAC Sulphonamides Sales by Region (2017-2022) & (K MT)

Table 43. APAC Sulphonamides Sales Market Share by Region (2017-2022)

Table 44. APAC Sulphonamides Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Sulphonamides Revenue Market Share by Region (2017-2022)

Table 46. APAC Sulphonamides Sales by Type (2017-2022) & (K MT)

Table 47. APAC Sulphonamides Sales Market Share by Type (2017-2022)

Table 48. APAC Sulphonamides Sales by Application (2017-2022) & (K MT)

Table 49. APAC Sulphonamides Sales Market Share by Application (2017-2022)

Table 50. Europe Sulphonamides Sales by Country (2017-2022) & (K MT)

Table 51. Europe Sulphonamides Sales Market Share by Country (2017-2022)

Table 52. Europe Sulphonamides Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Sulphonamides Revenue Market Share by Country (2017-2022)

Table 54. Europe Sulphonamides Sales by Type (2017-2022) & (K MT)

Table 55. Europe Sulphonamides Sales Market Share by Type (2017-2022)

Table 56. Europe Sulphonamides Sales by Application (2017-2022) & (K MT)

Table 57. Europe Sulphonamides Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Sulphonamides Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Sulphonamides Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Sulphonamides Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Sulphonamides Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Sulphonamides Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Sulphonamides Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Sulphonamides Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Sulphonamides Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Sulphonamides

Table 67. Key Market Challenges & Risks of Sulphonamides

Table 68. Key Industry Trends of Sulphonamides

Table 69. Sulphonamides Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Sulphonamides Distributors List

Table 72. Sulphonamides Customer List

Table 73. Global Sulphonamides Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Sulphonamides Sales Market Forecast by Region

Table 75. Global Sulphonamides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Sulphonamides Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Sulphonamides Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Sulphonamides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Sulphonamides Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Sulphonamides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Sulphonamides Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Sulphonamides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Sulphonamides Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Sulphonamides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Sulphonamides Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Sulphonamides Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Sulphonamides Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Sulphonamides Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Sulphonamides Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Sulphonamides Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Sulphonamides Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Sulphonamides Revenue Market Share Forecast by Application (2023-2028)

Table 93. Abbott Laboratories Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 94. Abbott Laboratories Sulphonamides Product Offered

Table 95. Abbott Laboratories Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. Abbott Laboratories Main Business

Table 97. Abbott Laboratories Latest Developments

Table 98. Boehringer Ingelheim Pharmaceuticals Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 99. Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Offered

Table 100. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Boehringer Ingelheim Pharmaceuticals Main Business

Table 102. Boehringer Ingelheim Pharmaceuticals Latest Developments

Table 103. Bayer AG Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 104. Bayer AG Sulphonamides Product Offered

Table 105. Bayer AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Bayer AG Main Business

Table 107. Bayer AG Latest Developments

Table 108. GlaxoSmithKline Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 109. GlaxoSmithKline Sulphonamides Product Offered

Table 110. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. GlaxoSmithKline Main Business

Table 112. GlaxoSmithKline Latest Developments

Table 113. King Pharmaceuticals Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 114. King Pharmaceuticals Sulphonamides Product Offered

Table 115. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. King Pharmaceuticals Main Business

Table 117. King Pharmaceuticals Latest Developments

Table 118. Mylan Pharmaceuticals Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 119. Mylan Pharmaceuticals Sulphonamides Product Offered

Table 120. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Mylan Pharmaceuticals Main Business

Table 122. Mylan Pharmaceuticals Latest Developments

Table 123. Novartis International AG Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 124. Novartis International AG Sulphonamides Product Offered

Table 125. Novartis International AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. Novartis International AG Main Business

Table 127. Novartis International AG Latest Developments

Table 128. Pfizer Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 129. Pfizer Sulphonamides Product Offered

Table 130. Pfizer Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. Pfizer Main Business

Table 132. Pfizer Latest Developments

Table 133. Par Pharmaceutical Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 134. Par Pharmaceutical Sulphonamides Product Offered

Table 135. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 136. Par Pharmaceutical Main Business

Table 137. Par Pharmaceutical Latest Developments

Table 138. Roche Holding AG Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 139. Roche Holding AG Sulphonamides Product Offered

Table 140. Roche Holding AG Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 141. Roche Holding AG Main Business

Table 142. Roche Holding AG Latest Developments

Table 143. Sanofi Aventis Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 144. Sanofi Aventis Sulphonamides Product Offered

Table 145. Sanofi Aventis Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 146. Sanofi Aventis Main Business

Table 147. Sanofi Aventis Latest Developments

Table 148. Stiefel Laboratories Basic Information, Sulphonamides Manufacturing Base, Sales Area and Its Competitors

Table 149. Stiefel Laboratories Sulphonamides Product Offered

Table 150. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 151. Stiefel Laboratories Main Business

Table 152. Stiefel Laboratories Latest Developments

List of Figures

Figure 1. Picture of Sulphonamides

Figure 2. Sulphonamides Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sulphonamides Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Sulphonamides Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sulphonamides Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Orally Absorbable Sulfonamide

Figure 10. Product Picture of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

Figure 11. Product Picture of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

Figure 12. Global Sulphonamides Sales Market Share by Type in 2021

Figure 13. Global Sulphonamides Revenue Market Share by Type (2017-2022)

Figure 14. Sulphonamides Consumed in Skin Infections

Figure 15. Global Sulphonamides Market: Skin Infections (2017-2022) & (K MT)

Figure 16. Sulphonamides Consumed in Gastro Intestinal Tract (GIT) Infection

Figure 17. Global Sulphonamides Market: Gastro Intestinal Tract (GIT) Infection (2017-2022) & (K MT)

Figure 18. Sulphonamides Consumed in Meningitis

Figure 19. Global Sulphonamides Market: Meningitis (2017-2022) & (K MT)

Figure 20. Global Sulphonamides Sales Market Share by Application (2017-2022)

Figure 21. Global Sulphonamides Revenue Market Share by Application in 2021

Figure 22. Sulphonamides Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Sulphonamides Revenue Market Share by Company in 2021

Figure 24. Global Sulphonamides Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Sulphonamides Revenue Market Share by Geographic Region in 2021

Figure 26. Global Sulphonamides Sales Market Share by Region (2017-2022)

Figure 27. Global Sulphonamides Revenue Market Share by Country/Region in 2021

Figure 28. Americas Sulphonamides Sales 2017-2022 (K MT)

Figure 29. Americas Sulphonamides Revenue 2017-2022 ($ Millions)

Figure 30. APAC Sulphonamides Sales 2017-2022 (K MT)

Figure 31. APAC Sulphonamides Revenue 2017-2022 ($ Millions)

Figure 32. Europe Sulphonamides Sales 2017-2022 (K MT)

Figure 33. Europe Sulphonamides Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Sulphonamides Sales 2017-2022 (K MT)

Figure 35. Middle East & Africa Sulphonamides Revenue 2017-2022 ($ Millions)

Figure 36. Americas Sulphonamides Sales Market Share by Country in 2021

Figure 37. Americas Sulphonamides Revenue Market Share by Country in 2021

Figure 38. United States Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Sulphonamides Sales Market Share by Region in 2021

Figure 43. APAC Sulphonamides Revenue Market Share by Regions in 2021

Figure 44. China Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Sulphonamides Sales Market Share by Country in 2021

Figure 51. Europe Sulphonamides Revenue Market Share by Country in 2021

Figure 52. Germany Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Sulphonamides Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Sulphonamides Revenue Market Share by Country in 2021

Figure 59. Egypt Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Sulphonamides Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Sulphonamides in 2021

Figure 65. Manufacturing Process Analysis of Sulphonamides

Figure 66. Industry Chain Structure of Sulphonamides

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390